Close
provider
Search result for "Solr search content"
Search Result for "hematology"
Clinical Trial
Phase Ib Clinical Trial of Loncastuximab and Roflumilast Added to R-CHOP (Lo-RR-CHOP) for Treatment Naïve High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
This study is an investigator-initiated, phase I, single arm, open label clinical trial that will enroll subjects with untreated diffuse large B-cell lymphoma (DLCBL) at high risk for poor outcome, defined as an NCCN-IPI score of 2 or higher.
Story
Mays Cancer Center awards and honors
A summary of several of the many awards and honors received by Mays Cancer Center and its researchers during Fiscal Year 2022.
provider
Katherine Cermin, DNP, APRN, FNP-BC, FNP-C Family Nurse Practitioner, Oncology Survivorship
provider
Andrew Brenner, MD, PhD Neuro-Oncology, Breast Oncology
provider
Georgios Fotopoulos, MD, PhD, FSMB Thoracic Oncology, Experimental Therapeutics
Story
What the People in This Building Taught Me About Health Care
It’s almost cliché. You hear, “You have cancer,” and you wonder if you’ve been given a death sentence.
Story
Consensus Statement from the Mays Cancer Center/UT Health San Antonio Joint Cancer Prevention and Screening Committee
The Mays Cancer Center/UT Health San Antonio Joint Cancer Prevention and Screening Committee includes clinicians and scientists from across UT Health.
provider
Brittany Altermatt, ANP Adult Nurse Practitioner, Gastrointestinal Oncology
provider